ORWH and partnering institutes, centers, and offices (ICOs) are excited to announce the awardees for the R01 and R21 Notices of Funding Opportunities (NOFOs), Understanding Chronic Conditions Understudied Among Women, which requested research applications on chronic conditions that affect women and individuals assigned female at birth.
The Office of Autoimmune Disease Research in the Office of Research on Women’s Health (OADR-ORWH) is pleased to introduce the investigators who received the 2024 Office of Autoimmune Disease Research R56 Research Awards. R56 awards support short-term, highly meritorious extramural research that falls just outside the funding limits of participating NIH institutes and centers.
The Women’s Health Innovation Summit is an annual event that accelerates innovation, investment, research, and partnerships to improve the access to and quality of health care for women worldwide.
ORWH has announced a new funding opportunity to address health disparities among groups of women in the U.S. that are underrepresented, underserved, and underreported in biomedical research.
In collaboration with ORWH and other participating NIH institutes, centers, and offices, the Office of Disease Prevention is seeking applications for “Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities.”
Medscape and the Women’s Brain Foundation collaborated with ORWH Director, Janine Austin Clayton, M.D., FARVO, on a new continuing medical education (CME) program, “The Female Void: Sex and Gender Considerations in Health Care with a Focus on the Female Brain.”
ORWH Associate Director for Interdisciplinary Research, Elizabeth Barr, Ph.D., recently presented at the GENDERACTIONplus Online Stakeholder Consultation on “Inclusive Gender Analysis in Research and Innovation Beyond the European Research Area” on October 1, 2024.
A new article by ORWH Health Science Policy Analyst Raven Hardy Richard, Ph.D., titled “A Conceptual Model to Achieve Health Equity in APOL-1 Clinical Studies,” leverages a socioecological model (SEM) framework to identify challenges and opportunities related to enhancing clinical study participation diversity for individuals with apolipoprotein L1 (APOL-1)-mediated kidney disease.
The National Institutes of Health has announced the winners of the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge, a prize competition that encourages the development of postpartum maternal health diagnostics for regions that have limited access to maternity care.